Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

NCT03648788 is registered in ClinicalTrials.gov with IlDong Pharmaceutical Co Ltd as lead sponsor.

NCT NCT03648788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03648788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe
Lead sponsor
IlDong Pharmaceutical Co Ltd
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2018
Completion date
August 31, 2024
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mixed dyslipidemia